Patents Assigned to Acadian Pharmaceuticals, Inc.
  • Publication number: 20080009489
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 10, 2008
    Applicant: Acadian Pharmaceuticals, Inc.
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen